American BioMedical Association 2009 IT investment and entrepreneurship seminars

November 14, 2009

American BioMedical Association (CABA) and the Sino-US Intellectual Property Law Association (CAIPLA), the United States and Chinese Medicine Practitioners Association (ACMA), America Chinese Entrepreneur Association (OCEAN), New England Chinese Information Network Association (NECINA) and New England Yushan Science and Technology Association (MJNE) and other agencies, on November 十四 日 (周六) twelve o'clock to half past nine p.m., at the Doubletree Hotel Boston (Doubletree Guest Suites, 400 Soldiers Field Road, Boston) held 2009 IT investment and entrepreneurship seminars, focused on technological innovation in the life sciences, investment hotspots and entrepreneurial opportunities.

The conference will invite entrepreneurs, professionals, scientists, engineers, executives, academic experts, as well as financial, investment, politics exchanges.

Speakers include Concert Pharmaceuticals CEO Roger Tung, CEO of the world's science and technology venture capital firm Mark Tang, linked by the Massachusetts Health Council (Commonwealth Of Massachusetts Health Connector Authority), chief marketing officer Kevin Counihan, Pfizer senior patent lawyer Konstantin Linnik, Rich 利拉纳 (Foley & Lardner) law firm senior lawyer Linda Ji, CEO of Shanghai Pharmaceutical (Shanghai Medicilon) Company Chen Chunlin, CEO of Wuxi good Zinfandel biopharmaceutical company (Wuxi Howfond Biopharma) Shen Lixin, Nexcelom founder of Biomedical Sciences and Chairman Jean Qiu, Huang Qing, vice president of Sandia Medical Technology (Charles Huang), Vice President Fang En (Fountain) Pharmaceutical Development Corporation Joanne Jiang et al.

Member Organizer admission free, non-members twenty ten dollars, you can register as a member of the site, Gala Dinner thirty yuan.

Enquiries can be made ​​online , or just meeting chairman Roger Xie ( ), Jinbo Lee ( jk.lee @ ) or Philip Zhang ( philip.zhang @ )